| Aberrant glycosylation in cancer: a novel molecular mechanism controlling metastasis A Magalhães, HO Duarte, CA Reis Cancer cell 31 (6), 733-735, 2017 | 143 | 2017 |
| The role of O-glycosylation in human disease A Magalhães, HO Duarte, CA Reis Molecular Aspects of Medicine 79, 100964, 2021 | 71 | 2021 |
| MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis D Barros-Silva, P Costa-Pinheiro, H Duarte, EJ Sousa, AF Evangelista, ... Cell death & disease 9 (2), 167, 2018 | 59 | 2018 |
| Mucin-Type O-Glycosylation in Gastric Carcinogenesis HO Duarte, D Freitas, C Gomes, J Gomes, A Magalhaes, CA Reis Biomolecules 6 (3), 33, 2016 | 48 | 2016 |
| Gastric cancer: basic aspects HO Duarte, J Gomes, JC Machado, CA Reis Helicobacter 23, e12523, 2018 | 42 | 2018 |
| Gastric cancer cell glycosylation as a modulator of the ErbB2 oncogenic receptor HO Duarte, M Balmaña, S Mereiter, H Osório, J Gomes, CA Reis International Journal of Molecular Sciences 18 (11), 2262, 2017 | 39 | 2017 |
| ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab HO Duarte, JG Rodrigues, C Gomes, PJ Hensbergen, ALH Ederveen, ... Oncogene 40 (21), 3719-3733, 2021 | 37 | 2021 |
| Glycans as targets for drug delivery in cancer F Diniz, P Coelho, HO Duarte, B Sarmento, CA Reis, J Gomes Cancers 14 (4), 911, 2022 | 25 | 2022 |
| Terminal α2, 6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells JG Rodrigues, HO Duarte, C Gomes, M Balmaña, ÁM Martins, ... Cellular Oncology 44, 835-850, 2021 | 23 | 2021 |
| CAR‐Ts: new perspectives in cancer therapy R Abrantes, HO Duarte, C Gomes, S Wälchli, CA Reis FEBS letters 596 (4), 403-416, 2022 | 21 | 2022 |
| Aberrant protein glycosylation in cancer: implications in targeted therapy JG Rodrigues, HO Duarte, CA Reis, J Gomes Biochemical Society Transactions 49 (2), 843-854, 2021 | 17 | 2021 |
| Insights on ErbB glycosylation–contributions to precision oncology HO Duarte, CA Reis, J Gomes Trends in Cancer 8 (6), 448-455, 2022 | 8 | 2022 |
| Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability B Leão, X Wen, HO Duarte, I Gullo, G Gonçalves, P Pontes, C Castelli, ... International Journal of Molecular Sciences 22 (3), 1340, 2021 | 3 | 2021 |
| Candida albicans chitinase 3 with potential as a vaccine antigen: production, purification, and characterisation A Costa‐Barbosa, D Ferreira, MI Pacheco, M Casal, HO Duarte, C Gomes, ... Biotechnology Journal 19 (1), 2300219, 2024 | 1 | 2024 |
| PO-248 Novel insights on the role of glycosylation in cancer: molecular functions and clinical applications J Gomes, H Duarte, S Meriter, C Gomes, D Freitas, D Campos, ... ESMO Open 3, A324, 2018 | 1 | 2018 |
| HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches MB Freitas, I Gullo, D Leitão, L Águas, C Oliveira, A Polónia, J Gomes, ... Cancers 16 (6), 1227, 2024 | | 2024 |
| Monensin as potential drug for treatment of SLeX-positive tumors AF Costa, E Senra, D Campos, I Faria-Ramos, L Santos-Ferreira, ... medRxiv, 2024.03. 11.24304048, 2024 | | 2024 |
| Targeting Carbohydrates in Cancer–Analytical and Biotechnological Tools HO Duarte, J Gomes, CA Reis Carbohydrate‐Based Therapeutics, 161-200, 2023 | | 2023 |
| Plant‐derived Durvalumab variants show efficient PD‐1/PD‐L1 blockade and therapeutically favourable FcR binding S Izadi, S Gumpelmair, P Coelho, HO Duarte, J Gomes, J Leitner, ... Plant Biotechnology Journal, 2023 | | 2023 |
| Candida albicans chitinase 3 with potential as a vaccine antigen: production, purification, and characterisation AAC Barbosa, D Ferreira, MI Pacheco, M Casal, HO Duarte, C Gomes, ... Wiley, 2023 | | 2023 |
